PGN-EDODM1

DRUG2 trials

Sponsors

PepGen Inc

Conditions

Myotonic Dystrophy 1

Phase 2

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

RecruitingNCT06667453

PepGen IncMyotonic Dystrophy 1

Start: 2024-12-10End: 2027-03-01Target: 24Updated: 2026-07-29

An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

RecruitingNCT07220603

PepGen IncMyotonic Dystrophy 1

Start: 2025-12-23End: 2029-01-01Target: 48Updated: 2026-03-30